Shares of Sun Pharma were down over 10 per cent today, following weak fourth quarter earnings. Consolidated net profit of Sun Pharmaceutical Industries - the country’s largest drug maker - fell 14 per cent year-on-year(y-o-y) to Rs 1,223 crore during the fourth quarter of 2016-17. The fall in net profit was mainly attributed to pricing erosion in the US base business coupled with higher fin...